BETA

Activities of Corinne LEPAGE related to 2010/2153(INI)

Shadow reports (1)

REPORT on evaluation of the management of H1N1 influenza in 2009-2010 in the EU PDF (194 KB) DOC (128 KB)
2016/11/22
Committee: ENVI
Dossiers: 2010/2153(INI)
Documents: PDF(194 KB) DOC(128 KB)

Amendments (6)

Amendment 18 #
Motion for a resolution
Recital B
B. whereas the criteria for defining a pandemic, adopted by the WHO in 2009 in its guidance document on ‘Pandemic influenza preparedness and response’ and based solely on the propagation of the virus while discounting the severity of the infection, distorted the meaning of the word ‘pandemic’ and triggered a false alarm worldwide, with thled authorities at EU level and in the Member States to take inappropriate alarmism giving rise to inappropriate public health decisions and a disproportionate response among the public and administrations of the European Union and its Member Statesnd disproportionate public health decisions and gave rise to public alarmism,
2010/12/20
Committee: ENVI
Amendment 33 #
Motion for a resolution
Recital C
C. whereas the exaggerated costs arising from the management of this crisis in the Member States are primarily a directto some extent a consequence of the EU’s lack of independence and critical acumen in relation to the risk evaluation conducted by the WHO,
2010/12/20
Committee: ENVI
Amendment 36 #
Motion for a resolution
Recital D
D. whereas the expenditure committed by the Member States to the response plans drawn up is mainly in connection with the purchase of vast quantities of vaccines, and antiviral treatments, and whereas purchasing procedures have led to serious concerns in terms of transparency and public procurement rules compliance in several Member States
2010/12/20
Committee: ENVI
Amendment 64 #
Motion for a resolution
Recital I
I. whereas confidence in vaccines against H1N1 influenza was also undermined by, in vaccine purchase contracts, the partial transfer, from the manufacturer to the Member State, in the purchase contracts, of liability for any side effectrelevant authorities of the Member State, of liability for any side effects contributed to a climate of suspicion about the vaccination campaigns and whether the vaccines were harmless,
2010/12/20
Committee: ENVI
Amendment 109 #
Motion for a resolution
Paragraph 4 a (new)
4a. Calls on the Commission and the Member States to supply details of the following: (1) the number of doses of vaccine ultimately purchased by each Member State; (2) total expenditure on the purchase of vaccines in each Member State; (3) the number of doses of vaccine actually used in each Member State; (4) the number of doses of vaccine which were, respectively, placed in storage, the subject of reimbursement, and sold to other Member States;
2010/12/20
Committee: ENVI
Amendment 141 #
Motion for a resolution
Paragraph 9
9. Calls foron the publication ofCommission to publish the names, roles and potential conflicts of interest of senior officials who are members of informal groups such as the EU’s Health Security Committee, the Health Emergency Operational Facility (HEOF) and the ‘vaccines’ task force;
2010/12/20
Committee: ENVI